Cite
MLA Citation
Kristina Ellwanger et al.. “EGFRvIII TandAbs are specific and highly potent drug candidates for the treatment of solid tumors.” Journal for immunotherapy of cancer, vol. 3, no. 2, 2015, p. 1. http://access.bl.uk/ark:/81055/vdc_100080441580.0x000048